Summary
CME Group Inc. (CME) has filed an 8-K report detailing an amendment to its employment agreement with Chairman and CEO Terrence A. Duffy, extending his tenure through December 31, 2024. This extension underscores the Board's confidence in Mr. Duffy's continued leadership, citing his crucial role in navigating market volatility, integrating acquisitions like NEX Group, and executing strategic partnerships such as the one with Google. The amendment includes a base salary increase to $2 million annually, effective January 1, 2022, with no changes to his target bonus or equity award opportunities. Additionally, Mr. Duffy will receive a one-time special bonus of $5 million, payable in March 2022. These compensation adjustments are justified by the Board based on Mr. Duffy's long-term contributions, strategic achievements, and commitment to shareholder value, dividend policy, and employee welfare.
Key Highlights
- 1Terrence A. Duffy's employment as Chairman and CEO extended through December 31, 2024.
- 2Annual base salary for Mr. Duffy increased from $1.5 million to $2 million, effective January 1, 2022.
- 3No changes were made to Mr. Duffy's annual target bonus or equity grant value opportunities.
- 4A one-time special bonus of $5 million will be paid to Mr. Duffy in March 2022.
- 5The Board cited Mr. Duffy's leadership during market volatility, strategic partnerships (e.g., Google), and acquisition integration (e.g., NEX Group) as key factors for the contract extension.
- 6The Board emphasized the importance of Mr. Duffy's continued leadership for delivering shareholder value and maintaining the company's dividend policy.
- 7Vesting of certain unvested equity awards after December 31, 2023, is linked to employment through December 31, 2024, and subject to a general release.